Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025)

Amarin Corp Plcuk (AMRN) posted quarterly Other Accumulated Expenses of $18.3 million for Q4 2025, up 4.52% YoY from $17.5 million in Q4 2024, and up 4.52% sequentially from $17.5 million in Q4 2024.

Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025) Analysis & Trends

Amarin Corp Plcuk has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $18.3 million for Q4 2025.

  • In Q4 2025, Other Accumulated Expenses rose 4.52% year-over-year to $18.3 million; the TTM figure through Dec 2025 stood at $18.3 million (up 4.52% YoY), while the FY2025 annual figure was $18.3 million, up 4.52% from the prior year.
  • Other Accumulated Expenses climbed to $18.3 million in Q4 2025, from $17.5 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for AMRN reached as high as $45.6 million in Q4 2021 and fell as low as $17.5 million in Q4 2024.
  • The 5-year median for Other Accumulated Expenses is $23.0 million (2023), against an average of $28.0 million.
  • Annual changes were most pronounced in 2021 — Other Accumulated Expenses surged 58.42% — and 2023, when it tumbled 35.41%.
  • A 5-year view of Other Accumulated Expenses shows it stood at $45.6 million in 2021, then fell by 21.84% to $35.6 million in 2022, then plunged by 35.41% to $23.0 million in 2023, then decreased by 23.79% to $17.5 million in 2024, then advanced by 4.52% to $18.3 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $18.3 million, $17.5 million, and $23.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 18.34 Mn
Dec 31, 2024 17.55 Mn
Dec 31, 2023 23.02 Mn
Dec 31, 2022 35.64 Mn
Dec 31, 2021 45.60 Mn
Dec 31, 2020 28.79 Mn
Dec 31, 2019 16.59 Mn
Dec 31, 2018 7.71 Mn
Dec 31, 2017 5.16 Mn
Dec 31, 2016 5.80 Mn
Dec 31, 2015 4.28 Mn
Dec 31, 2014 2.25 Mn
Dec 31, 2013 3.34 Mn
Dec 31, 2012 3.15 Mn
Dec 31, 2011 1.78 Mn
Dec 31, 2010 572,000.00